Table 9.
Disease | Genetic defect/presumed pathogenesis | Circulating T cells | Circulating B cells | Serum Ig | Associated features/similar PID |
---|---|---|---|---|---|
Associated with somatic mutations | |||||
Autoimmune lymphoproliferative syndrome (ALPS–SFAS) | Somatic mutation in TNFRSF6 | Increased CD4−CD8−double negative (DN) T alpha/beta cells | Normal, but increased number of CD5+ B cells | Normal or increased | Splenomegaly, lymphadenopathy, autoimmune cytopenias Defective lymphocyte apoptosis/ALPS–FAS (=ALPS type Im) |
RAS-associated autoimmune leukoproliferative disease (RALD) | Somatic mutation in KRAS (gain-of-function) | Normal | B cell lymphocytosis | Normal or increased | Splenomegaly, lymphadenopathy, autoimmune cytopenias, granulocytosis, monocytosis/ALPS-like |
RAS-associated autoimmune leukoproliferative disease (RALD) | Somatic mutation in NRAS (gain-of-function) | Increased CD4−CD8−double negative (DN) T alpha/beta cells | Lymphocytosis | Splenomegaly, lymphadenopathy, autoantibodies/ALPS-like | |
Cryopyrinopathy, (Muckle-Wells /CINCA/NOMID-like syndrome) | Somatic mutation in NLRP3 | Normal | Normal | Normal | Urticaria-like rash, arthropathy, neurological symptoms |
Associated with autoantibodies | |||||
Chronic mucocutaneous candidiasis (isolated or with APECED syndrome) | Germline mutation in AIRE AutoAb to IL-17 and/or IL-22 | Normal | Normal | Normal | Endocrinopathy, chronic mucocutaneous candidiasis/CMC |
Adult-onset immunodeficiency | AutoAb to IFN gamma | Decreased naive T cells | Normal | Normal | Mycobacterial, fungal, Salmonella VZV infections/MSMD, or CID |
Recurrent skin infection | AutoAb to IL-6 | Normal | Normal | Normal | Staphylococcal infections/STAT3 deficiency |
Pulmonary alveolar proteinosis | AutoAb to GM-CSF | Normal | Normal | Normal | Pulmonary alveolar proteinosis, cryptococcal meningitis/CSF2RA deficiency |
Acquired angioedema | AutoAb to CI inhibitor | Normal | Normal | Normal | Angioedema/C1 INH deficiency (hereditary angioedema) |
Atypical Hemolytic Uremic Syndrome | AutoAb to Complement Factor H | Normal | Normal | Normal | aHUS Spontaneous activation of the alternative complement pathway |